Join Cepheid at ESCMID 2026
April 17-21 - Munich, Germany
Cepheid will join the leading experts to share our cutting-edge technology, research and elaborate symposia during ESCMID 2026. We are looking forward to sharing more information about our participation and in-booth experiences for ESCMID 2026.
Sign up now with the form below and be first in-line, to receive more information about our upcoming program of in-booth experiences and integrated symposia.
Together, we are focused on solving complex health challenges for patients around the world, enabling healthcare providers to diagnose diseases with unprecedented speed and precision. Every moment matters when lives are at stake. There’s no time to wait.
Now Available: "Expert Insights on Diagnostics and Antimicrobial Resistance"
Get instant access to the Integrated Symposium from ESCMID 2025 and learn more aboutthe critical role of diagnostics in combating antimicrobial resistance (AMR). Expertshighlighted the importance of molecular diagnostics to enhance patient pathways and improve healthcare delivery.

Sign up to Stay up to Date for ESCMID 2026
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
About Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most from central laboratories and hospitals to near patient settings.
For more information, visit www.cepheid.com

©2026 Cepheid. All Rights Reserved.